Sodium kinase deficiency is a dubious disease in the field of genetic metabolism, with complex clinical manifestations and often involving multiple systems. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory testing and pathological activation.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnoses and treatment plans. Individualised treatment plans for treatment and management of Sodium kinase deficiency need to be developed, typically including multidimensional management, including drug therapy, rehabilitation interventions, regular follow-up, etc. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic disorders.
Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustment according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of phosphate kinase deficiency. The platform serves a team of nationally and internationally authoritative experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.